+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prioritizing putative influential genes in cardiovascular disease susceptibility by applying tissue-specific Mendelian randomization



Prioritizing putative influential genes in cardiovascular disease susceptibility by applying tissue-specific Mendelian randomization



Genome Medicine 11(1): 6



The extent to which changes in gene expression can influence cardiovascular disease risk across different tissue types has not yet been systematically explored. We have developed an analysis pipeline that integrates tissue-specific gene expression, Mendelian randomization and multiple-trait colocalization to develop functional mechanistic insight into the causal pathway from a genetic variant to a complex trait. We undertook an expression quantitative trait loci-wide association study to uncover genetic variants associated with both nearby gene expression and cardiovascular traits. Fine-mapping was performed to prioritize possible causal variants for detected associations. Two-sample Mendelian randomization (MR) was then applied using findings from genome-wide association studies (GWAS) to investigate whether changes in gene expression within certain tissue types may influence cardiovascular trait variation. We subsequently used Bayesian multiple-trait colocalization to further interrogate the findings and also gain insight into whether DNA methylation, as well as gene expression, may play a role in disease susceptibility. Finally, we applied our analysis pipeline genome-wide using summary statistics from large-scale GWAS. Eight genetic loci were associated with changes in gene expression and measures of cardiovascular function. Our MR analysis provided evidence of tissue-specific effects at multiple loci, of which the effects at the ADCY3 and FADS1 loci for body mass index and cholesterol, respectively, were particularly insightful. Multiple-trait colocalization uncovered evidence which suggested that changes in DNA methylation at the promoter region upstream of FADS1/TMEM258 may also affect cardiovascular trait variation along with gene expression. Furthermore, colocalization analyses uncovered evidence of tissue specificity between gene expression in liver tissue and cholesterol levels. Applying our pipeline genome-wide using summary statistics from GWAS uncovered 233 association signals at loci which represent promising candidates for further evaluation. Disease susceptibility can be influenced by differential changes in tissue-specific gene expression and DNA methylation. The approach undertaken in our study can be used to elucidate mechanisms in disease, as well as helping prioritize putative causal genes at associated loci where multiple nearby genes may be co-regulated. Future studies which continue to uncover quantitative trait loci for molecular traits across various tissue and cell types will further improve our capability to understand and prevent disease.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066446608

Download citation: RISBibTeXText

PMID: 30704512

DOI: 10.1186/s13073-019-0613-2


Related references

Mendelian Randomization Analysis Identifies CpG Sites as Putative Mediators for Genetic Influences on Cardiovascular Disease Risk. American Journal of Human Genetics 101(4): 590-602, 2017

Mendelian randomization: Its impact on cardiovascular disease. Journal of Cardiology 72(4): 307-313, 2018

Mendelian randomization: application to cardiovascular disease. Current Hypertension Reports 14(1): 29-37, 2012

Adiposity as a cause of cardiovascular disease: a Mendelian randomization study. International Journal of Epidemiology 44(2): 578-586, 2016

Moderate alcohol use and cardiovascular disease from Mendelian randomization. Plos One 8(7): E68054, 2014

Cystatin C and Cardiovascular Disease: A Mendelian Randomization Study. Journal of the American College of Cardiology 68(9): 934-945, 2017

Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. Journal of the American College of Cardiology 62(21): 1966-1976, 2014

Secretory Phospholipase A2-IIA and Cardiovascular Disease a Mendelian randomization study. Journal of the American College of Cardiology, 2013

Genetic risk factors and Mendelian randomization in cardiovascular disease. Current Cardiology Reports 17(5): 33, 2016

Using Mendelian randomization to determine causative factors in cardiovascular disease. Journal of Internal Medicine 273(1): 44-47, 2013

Tissue-specific functional networks for prioritizing phenotype and disease genes. Plos Computational Biology 8(9): E1002694, 2013

Coffee intake, cardiovascular disease and all-cause mortality: observational and Mendelian randomization analyses in 95 000-223 000 individuals. International Journal of Epidemiology 45(6): 1938-1952, 2016

Association between bilirubin and cardiovascular disease risk factors: using Mendelian randomization to assess causal inference. Bmc Cardiovascular Disorders 12: 16, 2012

Mendelian Randomization Analyses for Selection of Therapeutic Targets for Cardiovascular Disease Prevention: a Note of Circumspection. Cardiovascular Drugs and Therapy 30(1): 65-74, 2016

The Impact of Glycated Hemoglobin (HbA 1c ) on Cardiovascular Disease Risk: A Mendelian Randomization Study Using UK Biobank. Diabetes Care 41(9): 1991-1997, 2018